Clearance Summary
DETER. OF HEMOGLOBIN A2 USING THE DIAMAT received FDA 510(k) clearance under submission number K875102, sponsored by Bio-Rad. The device was reviewed via the Traditional premarket notification pathway and assigned to the Hematology review panel. The statutory decision date of record is 1988-02-24.
- Submission: K875102
- Applicant / Sponsor: Bio-Rad
- Clearance pathway: Traditional
- Review panel: Hematology
- Device class: Class II
- Regulation citation: 21 CFR 864.7400
- Decision date: 1988-02-24
Classification & Regulation
This clearance is catalogued under FDA product code JPD and 21 CFR 864.7400, within the Hematology review panel as a Class II device.